A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data
- 27 March 2014
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 53 (7) , 625-636
Abstract
Current cytochrome P450 (CYP) 1A2 and 3A4 ontogeny profiles, which are derived mainly from in vitro studies and incorporated in paediatric physiologically based pharmacokinetic models, have been reported to under-predict the in vivo clearances of some model substrates in neonates and infants. We report ontogeny functions for these enzymes as paediatric to adult relative intrinsic clearance per mg of hepatic microsomal protein, based on the deconvolution of in vivo pharmacokinetic data and by accounting for the impact of known clinical condition on hepatic unbound intrinsic clearance for caffeine and theophylline as markers of CYP1A2 activity and for midazolam as a marker of CYP3A4 activity. The function for CYP1A2 describes an increase in relative intrinsic metabolic clearance from birth to 3 years followed by a decrease to adult values. The function for CYP3A4 describes a continuous rise in relative intrinsic metabolic clearance, reaching the adult value at about 1.3 years of age. The new models were validated by showing improved predictions of the systemic clearances of ropivacaine (major CYP1A2 substrate; minor CYP3A4 substrate) and alfentanil (major CYP3A4 substrate) compared with those using a previous ontogeny function based on in vitro data (alfentanil: mean squared prediction error 3.0 vs. 6.8; ropivacaine: mean squared prediction error 2.3 vs.14.2). When implementing enzyme ontogeny functions, it is important to consider potential confounding factors (e.g. disease) that may affect the physiological conditions of the patient and, hence, the prediction of net in vivo clearance.Keywords
This publication has 44 references indexed in Scilit:
- Combining the ‘bottom up’ and ‘top down’ approaches in pharmacokinetic modelling: fittingPBPKmodels to observed clinical dataBritish Journal of Clinical Pharmacology, 2014
- Evaluation of a morphine maturation model for the prediction of morphine clearance in childrenBritish Journal of Clinical Pharmacology, 2011
- The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill PatientsClinical Pharmacokinetics, 2011
- Human renal function maturation: a quantitative description using weight and postmenstrual agePediatric Nephrology, 2009
- A Mechanistic Approach for the Scaling of Clearance in ChildrenClinical Pharmacokinetics, 2006
- Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and ChildrenClinical Pharmacokinetics, 2006
- Ontogeny of Hepatic and Renal Systemic Clearance Pathways in InfantsClinical Pharmacokinetics, 2002
- Fetal liver volume measurement by three‐dimensional ultrasonography: a preliminary studyUltrasound in Obstetrics & Gynecology, 1998
- A COMPARISON OF HEPATIC CYTOCHROME P450 PROTEIN EXPRESSION BETWEEN INFANCY AND POSTINFANCYLife Sciences, 1997
- Some suggestions for measuring predictive performanceJournal of Pharmacokinetics and Biopharmaceutics, 1981